Phase II study of oral S-1 in pretreated patients with recurrent or metastatic head and neck cancer

被引:0
|
作者
Park, S.
Lee, S.
Park, J.
Cho, E.
Shin, D.
Lee, J.
机构
[1] Gil Med Ctr, Inchon, South Korea
[2] Dankook Univ Hosp, Cheonan, South Korea
关键词
D O I
10.1200/jco.2008.26.15_suppl.17007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
17007
引用
收藏
页数:1
相关论文
共 50 条
  • [1] PHASE I PHARMACOKINETIC STUDY OF S-1 GRANULE AND NEDAPLATIN FOR PATIENTS WITH RECURRENT/METASTATIC HEAD AND NECK CANCER
    Tanaka, K.
    Hayashi, H.
    Okamoto, I.
    Ueda, S.
    Okamoto, K.
    Kawakami, H.
    Nishina, S.
    Takeda, M.
    Doi, K.
    Nakagawa, K.
    [J]. ANNALS OF ONCOLOGY, 2013, 24
  • [2] Phase I/II study of S-1 combined with carboplatin in recurrent and/or metastatic head and neck cancer as outpatient chemotherapy
    Watanabe, A
    Taniguchi, M
    Yamashita, T
    Ueda, M
    Abe, T
    Kusumi, T
    Hosokawa, M
    Sasaki, S
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2006, 28 (07): : 620 - 625
  • [3] Phase I study of oral S-1 and concurrent radiotherapy in patients with head and neck cancer
    Nakata, Kensei
    Sakata, Koh-ichi
    Someya, Masanori
    Miura, Katsutoshi
    Hayashi, Junichi
    Hori, Masakazu
    Takagi, Masaru
    Himi, Tetsuo
    Kondo, Atsushi
    Hareyama, Masato
    [J]. JOURNAL OF RADIATION RESEARCH, 2013, 54 (04) : 679 - 683
  • [4] Phase I Study of Oral S-1 and Concurrent Radiotherapy in Patients with Head and Neck Cancer
    Nakata, K.
    Someya, M.
    Takagi, M.
    Hayashi, J.
    Miura, K.
    Sakata, K.
    Hareyama, M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S450 - S451
  • [5] Phase I Study of S-1 plus Nedaplatin in Patients with Advanced/Recurrent Head and Neck Cancer
    Kogashiwa, Yasunao
    Yamauchi, Kohichi
    Nagafuji, Hiroshi
    Matsuda, Takehiro
    Tsubosaka, Toshihito
    Karaho, Takehiro
    Maruyama, Takeshi
    Kohno, Naoyuki
    [J]. CHEMOTHERAPY, 2010, 56 (06) : 453 - 458
  • [6] Phase II study of rubitecan in recurrent or metastatic head and neck cancer
    Francesco Caponigro
    Giacomo Cartenì
    Jean Pierre Droz
    Amalia Milano
    Wayne B. Davis
    Patricia Pollard
    [J]. Cancer Chemotherapy and Pharmacology, 2008, 62 : 209 - 214
  • [7] Safety and efficacy of S-1 chemotherapy in recurrent/metastatic head and neck cancer
    Suzuki, Shinsuke
    Ishikawa, Kazuo
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2009, 15 (05) : 335 - 339
  • [8] Phase I/II Study of S-1 plus Cisplatin Combination Chemotherapy in Patients with Advanced/Recurrent Head and Neck Cancer
    Fujii, Masato
    Tomita, Kitinobu
    Nishijima, Wataru
    Tsukuda, Mamoru
    Hasegawa, Yasuhisa
    Ishitoya, Junichi
    Yamane, Hideo
    Homma, Akihiro
    Tomita, Toshiki
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (03) : 214 - 221
  • [9] Phase II study of rubitecan in recurrent or metastatic head and neck cancer
    Caponigro, Francesco
    Carteni, Giacomo
    Droz, Jean Pierre
    Milano, Amalia
    Davis, Wayne B.
    Pollard, Patricia
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (02) : 209 - 214
  • [10] PHASE II STUDY OF S-1, AN ORAL FLUOROPYRIMIDINE, IN PATIENTS WITH ADVANCED OR RECURRENT CERVICAL CANCER
    Kamiura, S.
    Katsumata, N.
    Hirai, Y.
    Sugiyama, T.
    Kokawa, K.
    Hatae, M.
    Nishimura, R.
    Ochiai, K.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 213 - 213